218 related articles for article (PubMed ID: 31266997)
1. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
2. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
3. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
Garcia P; Harrod A; Jha S; Jenkins J; Barnhill A; Lee H; Thompson M; Williams JP; Barefield J; Mckinnon A; Suarez P; Shah A; Lowrey AJ; Bentz GL
Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.
Bentz GL; Shackelford J; Pagano JS
J Virol; 2012 Nov; 86(22):12251-61. PubMed ID: 22951831
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.
Bentz GL; Whitehurst CB; Pagano JS
J Virol; 2011 Oct; 85(19):10144-53. PubMed ID: 21795333
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.
Lu H; Liu B; Zhang FJ; Zhang J; Dong R; Chen L; Qu DM; Lu Y; Yu BW
Cell Cycle; 2014; 13(24):3892-902. PubMed ID: 25483061
[TBL] [Abstract][Full Text] [Related]
8. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
9. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
10. RPS27a enhances EBV-encoded LMP1-mediated proliferation and invasion by stabilizing of LMP1.
Hong SW; Kim SM; Jin DH; Kim YS; Hur DY
Biochem Biophys Res Commun; 2017 Sep; 491(2):303-309. PubMed ID: 28735865
[TBL] [Abstract][Full Text] [Related]
11. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
[TBL] [Abstract][Full Text] [Related]
12. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
Ning S; Pagano JS
J Virol; 2010 Jun; 84(12):6130-8. PubMed ID: 20392859
[TBL] [Abstract][Full Text] [Related]
13. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
Fries KL; Miller WE; Raab-Traub N
J Virol; 1996 Dec; 70(12):8653-9. PubMed ID: 8970991
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin CD63 Bridges Autophagic and Endosomal Processes To Regulate Exosomal Secretion and Intracellular Signaling of Epstein-Barr Virus LMP1.
Hurwitz SN; Cheerathodi MR; Nkosi D; York SB; Meckes DG
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212935
[TBL] [Abstract][Full Text] [Related]
16. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
17. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
Wang H; You G
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
[TBL] [Abstract][Full Text] [Related]
18. SUMO1/sentrin/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions.
Liu SL; Gao FH
Biochimie; 2018 Sep; 152():6-13. PubMed ID: 29908207
[TBL] [Abstract][Full Text] [Related]
19. CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.
Hurwitz SN; Nkosi D; Conlon MM; York SB; Liu X; Tremblay DC; Meckes DG
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974566
[TBL] [Abstract][Full Text] [Related]
20. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.
Itahana Y; Yeh ET; Zhang Y
Mol Cell Biol; 2006 Jun; 26(12):4675-89. PubMed ID: 16738331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
